Literature DB >> 35570982

Response to "Nephronophthisis Is an Important Differential Diagnosis of Nonspecific Interstitial Nephritis in Adults".

Mira Choi1, Carsten Bergmann2.   

Abstract

Entities:  

Year:  2022        PMID: 35570982      PMCID: PMC9091583          DOI: 10.1016/j.ekir.2022.03.010

Source DB:  PubMed          Journal:  Kidney Int Rep        ISSN: 2468-0249


× No keyword cloud information.
The Authors Reply: We thank Gillion et al. for their interesting contribution in response to our article that perfectly matches our view and strengthens our message. The authors’ case series underlines that nephronophthisis needs to be considered for differential diagnosis of interstitial nephritis in adults even in the absence of polyuria, proteinuria, hematuria, and/or extrarenal symptoms. Nephronophthisis belongs to the group of cystic kidney diseases and ciliopathies characterized by tubulointerstitial findings, such as fibrosis. Remarkably, kidney cysts if any usually only occur late during the clinical course. A comprehensive genetic testing approach is crucial; only for nephronophthisis, we are aware of >30 genes currently known. The patients described by Gillion et al. emphasize the increasing importance of reverse phenotyping by genetics. There is growing evidence that a considerable fraction of adult nephrology patients currently classified as nongenetic actually harbor a monogenic cause for their kidney disease. This report also nicely illustrates that knowledge of the underlying genotype has direct clinical implications for patients and families and is useful in terms of therapy, care, and prognosis.
  2 in total

1.  Nephronophthisis Is an Important Differential Diagnosis of Nonspecific Interstitial Nephritis in Adults.

Authors:  Valentine Gillion; Karin Dahan; Michel Jadoul; Nathalie Demoulin
Journal:  Kidney Int Rep       Date:  2022-03-16

2.  Interstitial Nephritis: A Change in Diagnosis With Next-Generation Sequencing.

Authors:  Mira Choi; Anne Rübsam; Marten Schulz; Eva Decker; Anja Friedrich; Eva Schrezenmeier; Fabian Halleck; Kai-Uwe Eckardt; Carsten Bergmann
Journal:  Kidney Int Rep       Date:  2022-02-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.